针对系统性红斑狼的CAR T细胞疗法:目前的情况和未来的前景
Jincai Zhou1, Bixia Lei1, Feifei Shi1
1Innovation & Research Department, OriCell Therapeutics Co. Ltd., Shanghai, China.
Frontiers in immunology
|January 3, 2025
概括
化学抗原受体T细胞 (CAR-T) 疗法通过向B细胞来治疗全身性红斑狼 (SLE) 是有前途的. 这种创新方法可能为患有严重或耐火性狼性炎 (LN) 的患者提供新的希望.
科学领域:
- 免疫学 免疫学 免疫学
- 自免疫性疾病 自免疫性疾病
- 细胞疗法细胞疗法
背景情况:
- 系统性红斑狼 (SLE) 和狼性炎 (LN) 是自身免疫性疾病,导致严重的器官损伤.
- 目前用于SLE/LN的治疗方法不足,需要新的治疗策略.
- 化学抗原受体T细胞 (CAR-T) 疗法在B细胞恶性瘤中取得了成功,目前正在研究非恶性自身免疫性疾病.
研究的目的:
- 分析SLE的CAR-T疗法的进展.
- 探索CAR-T疗法的潜力,以彻底改变SLE治疗.
- 审查SLE中CAR-T的免疫基础和临床数据.
主要方法:
- 关于SLE的CAR-T治疗的最新研究和临床数据的审查.
- 分析CAR-T细胞机制及其在SLE中的应用.
- 对抗CD19和抗BCMA CAR-T细胞的评估,这些细胞向SLE中的B细胞.
主要成果:
- 卡特-T疗法在向SLE中的B细胞方面显示出有前途的结果.
- 临床数据表明抗CD19和抗BCMACAR-T细胞的潜在安全性和有效性.
- 卡特-T疗法可以改善严重或耐性SLE病例的结果.
结论:
- 卡特-T疗法代表了SLE和LN治疗的潜在突破.
- 整合CAR-T疗法为自身免疫研究和临床实践提供了新的视野.
- 持续的研究和优化对于在SLE中推进CAR-T战略至关重要.
相关概念视频
Tumor Immunotherapy
394
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
394
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Mesenchymal Stem Cells
4.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.5K
Autoimmune Disorders
313
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
313
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
T Cell Types and Functions
613
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
613
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

